성인에서 참고구간 내의 혈중 Gamma-glutamyltransferase 농도에 따른 대사증후군 및 제2형 당뇨병 발병률과의 관련성
Relationship between Serum Gamma-glutamyltransferase Levels within Reference Intervals and the Prevalence of Metabolic Syndrome and Diabetes Mellitus in Adults
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
배경: 본 연구에서는 건강한 성인에서 혈중 GGT 농도의 참고구간을 설정하고, 참고구간 내의 혈중 GGT 농도에 따른 대사증후군 및제2형 당뇨병 발병률과의 연관성을 분석하고자 하였다. 방법: 혈중 GGT 농도의 참고구간의 설정을 위해 총 363명(남자137명, 여자 226명)의 건강한 성인을 대상으로 하였다. 2011년 3월부터 10월까지 한 대학병원의 건강증진센터를 방문하여 본 연구에 동의하고 건강검진을 실시한 총 919명(남자 519명, 여자 400명)을 대상으로 단면조사연구를 시행하였다. 남자와 여자의 혈중GGT 농도의 참고구간을 4군으로 나누어 대사증후군과 제2형 당뇨병의 발병률의 관련성을 분석하였다. 결과: 중앙 95백분위수에 의한 혈중 GGT 농도의 참고구간은 남자에서 9.0-70.6 IU/L 그리고 여자에서 4.0-31.3 IU/L였다. 참고구간 내의 혈중 GGT 농도의 사분위수군에 따른 대사증후군 유병률의 대응 위험도(95% CI)는 남자와 여자에서 각각 1.0, 3.6 (0.7-18.0), 8.8(2.0-39.1), 17.4 (4.0-75.3)와 1.0, 3.3 (0.6-16.6), 5.8 (1.2-27.3), 18.8(4.3-82.2)였고, 제2형 당뇨병에 대해서는 각각 1.0, 1.0 (0.3-3.0), 1.7(0.6-4.6), 2.6 (1.0-6.6)과 1.0, 1.6 (0.3-9.7), 1.6 (0.3-9.9), 8.0 (1.7-36.7)였다. 이러한 연관성은 나이, 알코올 섭취, BMI 및 흡연유무로 보정한 후에도 유지되었다. 결론: 혈중 GGT 농도는 참고구간내의 농도라 할지라도 대사증후군 및 제2형 당뇨병의 발병률과 용량-반응관계의 연관성을 나타냈다. 따라서 혈중 GGT 농도는 만성퇴행성질환에 대해 하나의 독립적 예측인자가 될 수 있을 것이다.
Abstract
Background: This study was conducted to establish reference intervals (RIs) for serum gamma-glutamyltransferase (GGT), and to evaluate the association between serum GGT levels within RIs and the prevalence of metabolic syndrome (MetS) and type 2 diabetes mellitus (DM) in men and women. Methods: A total of 363 healthy adults (137 men and 226 women) were enrolled for establishing the RIs of serum GGT. A cross-sectional study was conducted with 919 individuals (519 men and 400 women) to evaluate the associations between gender-specific serum GGT RI quartiles and prevalence of MetS and DM. Results: The RIs for serum GGT levels (central 95th percentile ranges) were 9.0-70.6 IU/L and 4.0-31.3 IU/L in men and women, respectively. In men, the odds ratios (ORs) and 95% confidence intervals (CIs) for the prevalence of MetS in 4 serum GGT quartiles (lowest to highest) were 1.0 (reference), 3.6 (0.7-18.0), 8.8 (2.0-39.1), and 17.4 (4.0-75.3), respectively, while the ORs (95% CIs) for the prevalence of DM were 1.0 (reference), 1.0 (0.3-3.0), 1.7 (0.6-4.6), and 2.6 (1.0-6.6), respectively. In women, the corresponding ORs (95% CIs) were 1.0 (reference), 3.3 (0.6-16.6), 5.8 (1.2-27.3), and 18.8 (4.3-82.2) for MetS, respectively, and 1.0 (reference), 1.6 (0.3-9.7), 1.6 (0.3-9.9), and 8.0 (1.7-36.7) for DM, respectively. These significant relationships persisted after adjusting for age, alcohol intake, body mass index, and smoking. Conclusions: Serum GGT levels, even within RIs, were proportionally associated with prevalence of metabolic syndrome and DM in both men and women. Serum GGT level may be an independent predictor for chronic degenerative diseases.
참고문헌 (39)
- Nakanishi N, "Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men", Diabetes Care, 27, pp.1427~1432 (2004)
- Rantala AO, "Gamma-glutamyl transpeptidase and the metabolic syndrome", J Intern Med, 248, pp.230~238 (2000)
- Teschke R, "Strohmeyer G. Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption", Biochem Biophys Res Commun, 75, pp.718~724 (1977)
- Lee DH, "Gamma-glutamyltransferase and diabetes--a 4 year follow-up study.", Diabetologia, 46, pp.359~364 (2003)
- Perry IJ, "Prospective study of serum gamma-glutamyltransferase and risk of NIDDM", Diabetes Care, 21, pp.732~737 (1998)
- Miura K, "Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers", J Hum Hypertens, 8, pp.445~449 (1994)
- Jousilahti P, "Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke", Stroke, 31, pp.1851~1855 (2000)
- Brenner H, "Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany", Prev Med, 26, pp.305~310 (1997)
- Higashi Y, "Endothelial function and oxidative stress in renovascular hypertension", N Engl J Med, 346, pp.1954~1962 (2002)
- Witztum JL, "Oxidized phospholipids and isoprostanes in atherosclerosis", Curr Opin Lipidol, 9, pp.441~448 (1998)
- Chisolm GM, "The oxidative modification hypothesis of atherogenesis: an overview", Free Radic Biol Med, 28, pp.1815~1826 (2000)
- Walter MF, "Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study", J Am Coll Cardiol, 44, pp.1996~2002 (2004)
- Taysi S, "Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis", Rheumatol Int, 21, pp.200~204 (2002)
- Niwa Y, "Auto-oxidative damage in Behcet’s disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils", Clin Exp Immunol, 49, pp.247~255 (1982)
- Zhang J, "Parkinson’s disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons", Am J Pathol, 154, pp.1423~1429 (1999)
- Carlisle ML, "Gamma-glutamyl transpeptidase activity alters the T cell response to oxidative stress and Fas-induced apoptosis", Int Immunol, 15, pp.17~27 (2003)
- Lee DH, "Is serum gamma glutamyltransferase a marker of oxidative stress?", Free Radic Res, 38, pp.535~539 (2004)
- Lee DH, "Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study", Clin Chem, 49, pp.1358~1366 (2003)
- Lee DH, "Gamma- Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women", J Clin Endocrinol Metab, 89, pp.5410~5414 (2004)
- Lim JS, "A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey", Clin Chem, 53, pp.1092~1098 (2007)
- Lee DH, "Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase: results from the National Health and Examination Survey 1999-2002", Clin Chem, 52, pp.1825~1827 (2006)
- Lee DH, "A strong dose-response relation between serum concentrations of per sistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002", Diabetes Care, 29, pp.1638~1644 (2006)
- Suh I., "Cardiovascular mortality in Korea: a country experiencing epidemiologic transition", Acta Cardiol, 56, pp.75~81 (2001)
- Clinical and Laboratory Standards Institute, "Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline", Clinical and Laboratory Standards Institute, ~ (2008)
- "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
- World Health Organization., "The Asia-Pacific perspective: Redefining obesity and its treatment" (2000), IOTF
- Kim SH, "Normal serum r-glutamyl transpeptidase activity of normal Koreans", J Korean Surg Soc, 1977, pp.33~41 (1977)
- Lee DH, "A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men", Am J Epidemiol, 163, pp.57~65 (2006)
- Ross JS, "Atherosclerosis and cancer: common molecular pathways of disease development and progression", Ann N Y Acad Sci, 947, pp.271~292 (2001)
- Droge W, "Free radicals in the physiological control of cell function", Physiol Rev, 82, pp.47~95 (2002)
- Kim DJ, "Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors", Diabet Med, 22, pp.1134~1140 (2005)
- Kang YH, "The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults.", Diabetes Res Clin Pract, 77, pp.306~313 (2007)
- 이미영, "혈청 감마지티(gamma-glutamyltransferase)와 당뇨병 유병률과의 상관관계", 대한내과학회지, 67(5), pp.498~505 (2004), 대한내과학회
- Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
- Yokoyama H, "Significant correlation between insulin resistance and serum gamma-glutamyl transpeptidase (gamma-GTP) activity in non-drinkers", Alcohol Clin Exp Res, 26, pp.91S~91S (2002)
- Ortega E, "Serum gammaglutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children", J Clin Endocrinol Metab, 91, pp.1419~1422 (2006)
- Ceriello A, "Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited", Arterioscler Thromb Vasc Biol, 24, pp.816~823 (2004)
- Lee DH, "Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes?", Diabetologia, 51, pp.402~407 (2008)
- Lee DH, "Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants?", Free Radic Res, 43, pp.533~537 (2009)
